molecular pathogenesis and immune dysregulation in mds
Published 2 years ago • 129 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:38
the role and targeting of immune dysregulation in mds
-
1:32
the role of the innate immune system in mds pathogenesis
-
2:49
the role of the immune system in the pathophysiology of mds
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
5:38
the molecular and clinical classifications of mds
-
9:41
the i4mds consortium and immune monitoring in mds
-
4:28
understanding myelodysplastic syndromes (mds)
-
9:10
mds: the current understanding in molecular testing and biomarkers
-
10:36
pathology cytogenetics bscmlt3yr june10
-
1:41
an overview of the mds diagnosis pathway
-
2:47
molecular background studies to aid diagnosis and treatment of mds
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
3:23
molecular characteristics associated with increased risk of disease progression in smm
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
1:57
combining molecular and clinical data to predict survival & transformation risk in patients with mds
-
5:36
mds biology: somatic mutations, the microenvironment & inflammation
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
3:10
the role of ngs in mds diagnosis
-
1:06
long-term outcomes of the ocean study: melflufen is superior to pomalidomide in r/r myeloma
-
1:36
identification of high-risk disease using molecular profiling by mymap
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy